Articles

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Hematology Department, Hospital del Mar, IMIM, UAB, Barcelona, Spain
Hematotherapy and Hemostasis Department, Hospital Clínic, Barcelona, Spain
Center for Research and Innovation of MPN (CRIMM); AOU Careggi, and Department of Experimental and Clinical Medicine, University of Florence, Italy
Hematology Department, Hospital Clínico, Valencia, Spain
Hematotherapy and Hemostasis Department, Hospital Clínic, Barcelona, Spain
Hematology and Medical Oncology Department, Hospital Morales Messeguer, IMIB-Arrixaca, UCAM, Murcia, Spain
Haematology Department, Guys’ and St Thomas’ NHS Foundation Trust, London, UK
Hematology, Oncology & Palliative Care, Johannes Wesling Academic Medical Center, University of Hannover Teaching Hospital, Germany
Hematology Department, Hospital La Paz, Madrid, Spain
Hematology Section, Uddevalla Hospital, NU Hospital Group, Sweden
Hematology Department, Hospital Príncipe de Asturias, Alcalá de Henares, Spain
Institute of Hematology & Blood Transfusion, Prague, Czech Republic
Hematology Department, Hospital Ramón y Cajal, Madrid, Spain
Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
Hematology Department, Hospital Vall d’Hebron, Barcelona, Spain
Hematology Department, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain
Center for Research and Innovation of MPN (CRIMM); AOU Careggi, and Department of Experimental and Clinical Medicine, University of Florence, Italy
Division of Hematology, University Hospital Basel, Switzerland
Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands
Centre for Cancer Research and Cell Biology, Queen’s University, Belfast, UK
Department of Clinical Science and Education, Karolinska Institute, South Hospital, Stockholm, Sweden
Haematology Department, Guys’ and St Thomas’ NHS Foundation Trust, London, UK
Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain
Center for Research and Innovation of MPN (CRIMM); AOU Careggi, and Department of Experimental and Clinical Medicine, University of Florence, Italy
Hematology Department, Hospital del Mar, IMIM, UAB, Barcelona, Spain
Vol. 101 No. 8 (2016): August, 2016 https://doi.org/10.3324/haematol.2016.146654